Tag results:
p53
Dermal Cell News
p53 Directs Leader Cell Behavior, Migration, and Clearance during Epithelial Repair
[Science] Scientists characterized leader cells emerging from epithelial monolayers in cell culture and found that they activated the stress sensor p53, which was sufficient to initiate leader cell behavior.
Pulmonary Cell News
Co-Occurrence CDK4/6 Amplification Serves as Biomarkers of De Novo EGFR TKI Resistance in Sensitizing EGFR Mutation Non-Small Cell Lung Cancer
[Scientific Reports] Scientists explored clinical factors in 332 advanced NSCLC who received EGFR TKI and molecular characteristics through 65 whole exome sequencing of various EGFR TKI responses including; de novo, intermediate response and long-term response.
Mammary Cell News
Intracellular CYTL1, a Novel Tumor Suppressor, Stabilizes NDUFV1 to Inhibit Metabolic Reprogramming in Breast Cancer
[Signal Transduction and Targeted Therapy] Researchers demonstrated that intracellular cytokine-like protein 1 (CYTL1) played a key role in preventing the robust glycolytic switching characteristics of breast cancer.
Immune Regulation News
Combining p53 mRNA Nanotherapy with Immune Checkpoint Blockade Reprograms the Immune Microenvironment for Effective Cancer Therapy
[Nature Communications] The authors developed and optimized a CXCR4-targeted mRNA nanoparticle platform to effectively induce p53 expression in hepatocellular carcinoma models.
Intestinal Cell News
PTBP3 Modulates P53 Expression and Promotes Colorectal Cancer Cell Proliferation by Maintaining UBE4A mRNA Stability
[Cell Death & Disease] PTBP3 knockdown in colorectal cancer cell lines restricted colorectal cancer proliferative capacities in vitro and in vivo.
Extracellular Matrix News
Inflammatory Fibroblasts Mediate Resistance to Neoadjuvant Therapy in Rectal Cancer
[Cancer Cell] Investigators showed that, upon irradiation, interleukin-1α (IL-1α) not only polarized cancer-associated fibroblasts (CAFs) toward the inflammatory phenotype but also triggered oxidative DNA damage, thereby predisposing inflammatory CAFs to p53-mediated therapy-induced senescence, which in turn resulted in chemoradiotherapy resistance and disease progression.